The invention provides a composition comprising an extract of Artocarpus heterophyllus and methods using and manufacturing the composition in the treatment of lower urinary tract symptoms (LUTS). The extract can be derived from the leaves of Artocarpus heterophyllus and can be formulated with carriers, excipients, nutritional supplements, food supplements, and beverages. The extract finds use in the treatment of LUTS associated with prostate disorders, such as benign prostatic hyperplasia. The composition can similarly be administered in methods of promoting and maintaining the health of the urinary tract and prostate.

The invention provides a composition comprising an extract of Artocarpus heterophyllus and methods using and manufacturing the composition in the treatment of lower urinary tract symptoms (LUTS). The extract can be derived from the leaves of Artocarpus heterophyllus and can be formulated with carriers, excipients, nutritional supplements, food supplements, and beverages. The extract finds use in the treatment of LUTS associated with prostate disorders, such as benign prostatic hyperplasia. The composition can similarly be administered in methods of promoting and maintaining the health of the urinary tract and prostate.

A topical skin cream is provided. The topical skin cream includes Acalypha indica oil, Rosa damascena Mill oil, at least one emulsion stabilizer, at least one exfoliant, at least one preservative and water. In an embodiment, the topical skin cream may include Acalypha indica oil, Rosa damascena Mill oil, hydroxypropylmethyl cellulose, polyethylene glycol, sucrose, an alpha-hydroxy acid, water, and at least one preservative. The topical skin cream can be used to treat various related problems, including but not limited to treatment of acne, fungal infections, skin allergies, and other skin conditions.

A topical skin cream is provided. The topical skin cream includes Acalypha indica oil, Rosa damascena Mill oil, at least one emulsion stabilizer, at least one exfoliant, at least one preservative and water. In an embodiment, the topical skin cream may include Acalypha indica oil, Rosa damascena Mill oil, hydroxypropylmethyl cellulose, polyethylene glycol, sucrose, an alpha-hydroxy acid, water, and at least one preservative. The topical skin cream can be used to treat various related problems, including but not limited to treatment of acne, fungal infections, skin allergies, and other skin conditions.

An acid-relief agent comprising a fermented vegetable extract obtained from a mixture of banana leaves, sweet potato roots, potato skin, seaweed, grape leaves, tendrils leaves, fig roots, emperor bean roots, and deep sea water; and nanocalcium mineral powder obtained from the thermal decomposition and grinding of a mixture of mica ore, mother of pearl, oyster shells. and oyster bay.

An acid-relief agent comprising a fermented vegetable extract obtained from a mixture of banana leaves, sweet potato roots, potato skin, seaweed, grape leaves, tendrils leaves, fig roots, emperor bean roots, and deep sea water; and nanocalcium mineral powder obtained from the thermal decomposition and grinding of a mixture of mica ore, mother of pearl, oyster shells. and oyster bay.

An acid-relief agent comprising a fermented vegetable extract obtained from a mixture of banana leaves, sweet potato roots, potato skin, seaweed, grape leaves, tendrils leaves, fig roots, emperor bean roots, and deep sea water; and nanocalcium mineral powder obtained from the thermal decomposition and grinding of a mixture of mica ore, mother of pearl, oyster shells. and oyster bay.

The present disclosure relates to a resveratrol delivery system having modified resveratrol composition wherein the active ingredient is stable colloidal resveratrol nanoparticles in unconjugated form. The said composition and its process thereof can be used in numerous applications for treatment of a mammal susceptible to or afflicted with insulin resistance, metabolic syndrome, aging, apoptosis, inflammation, stress resistance, cancer, cardiovascular disease, muscular dystrophy, low fertility rates or any combination thereof since the modified resveratrol composition has higher bioavailability and greater half-life.

The present disclosure relates to a resveratrol delivery system having modified resveratrol composition wherein the active ingredient is stable colloidal resveratrol nanoparticles in unconjugated form. The said composition and its process thereof can be used in numerous applications for treatment of a mammal susceptible to or afflicted with insulin resistance, metabolic syndrome, aging, apoptosis, inflammation, stress resistance, cancer, cardiovascular disease, muscular dystrophy, low fertility rates or any combination thereof since the modified resveratrol composition has higher bioavailability and greater half-life.

Therapeutic tea remedy mixtures in the form of beverages and ointments. Methods for making the tea remedy mixtures are described along with the benefits it provides to combat various medical ailments that frequently impair the human body.